Health ❯ Women's Health

Abortion

Medication Abortion Mifepristone Medical Ethics Abortion Pill Medical Abortion Medication Abortion Drugs Legislation Health Risks Abortion Pills Access Medication Abortions Abortion Restrictions Healthcare Access Medical Care Mifepristone and Misoprostol Chemical Abortions South Carolina Self-Managed Abortion Medical Necessity Physician Training Maternal Mortality Abortion Policy Legal Aspects Planned Parenthood Legalization Access to Care Clinic Abortion Drug Abortion Bans Abortion Drug Mifepristone In-Office Procedures Access to Healthcare Chemical Abortion Drugs Abortion Activists Physicians Post-Abortion Syndrome Support Systems Legal Restrictions Medical Risks

South Korea Plans Phased Rollout of Abortion Pills by Q1 2027

Officials say limiting prescriptions to doctors for an initial two years is meant to curb unsafe online purchases.

Olivia Rodrigo Partners With Center for Reproductive Rights to Spotlight Threats to Abortion Access

Poll Finds Broad Support to Restore In‑Person Rules for Abortion Pills

Louisiana’s Challenge to FDA’s Mifepristone Mail-Order Rule Heard in Federal Court

Tennessee Bill Would Allow Fetal-Homicide Charges for Abortion Patients

UN Warns 4.5 Million Girls Face FGM Risk in 2026 as Gambia Upholds Ban

Supreme Court Orders New York to Reexamine Religious Exemptions in Abortion Coverage Rule